Share This Page
Drug Price Trends for SM LORATADINE
✉ Email this page to a colleague
Average Pharmacy Cost for SM LORATADINE
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SM LORATADINE 10 MG TABLET | 70677-0134-01 | 0.05832 | EACH | 2025-03-19 |
| SM LORATADINE 5 MG/5 ML SYRUP | 49348-0636-34 | 0.04133 | ML | 2025-03-19 |
| SM LORATADINE 10 MG TABLET | 70677-0134-01 | 0.05618 | EACH | 2025-02-19 |
| SM LORATADINE-D 12 HOUR TABLET | 70677-0036-01 | 0.78654 | EACH | 2025-02-19 |
| SM LORATADINE 5 MG/5 ML SYRUP | 49348-0636-34 | 0.04165 | ML | 2025-02-19 |
| SM LORATADINE-D 12 HOUR TABLET | 70677-0036-01 | 0.77870 | EACH | 2025-01-22 |
| SM LORATADINE 10 MG TABLET | 70677-0134-01 | 0.05194 | EACH | 2025-01-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Loratadine Market Analysis and Price Projections
Overview of Loratadine
Loratadine, a second-generation antihistamine, is widely used to alleviate symptoms associated with allergies such as hay fever, allergic rhinitis, and urticaria. It is known for its non-drowsy formulation, making it a preferred choice for managing allergic conditions.
Market Size and Growth
The global loratadine market was valued at approximately USD 153.4 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2030[1][3][4].
- Global Market Size: The market size is projected to reach around USD 186.33 million by 2029, driven by the increasing prevalence of allergic conditions globally[3].
- Regional Dominance: North America currently holds the largest market share, primarily due to the high disease burden and the strong presence of several manufacturers in the region[1][4][5].
Drivers of Market Growth
Several factors are driving the growth of the loratadine market:
- Increasing Prevalence of Allergies: The global prevalence of allergic rhinitis is estimated to be between 10% and 30%, affecting approximately 400 million people worldwide. This high prevalence rate is a significant driver of market growth[1][4].
- Changing Lifestyles and Environmental Factors: Changes in lifestyles and exposure to environmental pollutants have increased the incidence of allergic conditions, thereby boosting the demand for loratadine[1][3].
- COVID-19 Impact: The COVID-19 pandemic has heightened awareness regarding respiratory health, leading to increased demand for antihistamines like loratadine. Additionally, studies have explored the potential of loratadine in managing COVID-19 symptoms, further impacting market growth[1][5].
Market Segmentation
The loratadine market is segmented based on several criteria:
- Dosage Form: The market is segmented into tablets, capsules, syrups, and other dosage forms. Tablets dominated the market in 2023, accounting for USD 63.5 million[4].
- Route of Administration: The oral segment dominates the market, holding 87% of the market share in 2023[4].
- Type: The market is categorized into branded and generic segments. The branded segment dominated the market and is predicted to grow at a CAGR of 2.6% over the forecast period[4].
- Distribution Channel: The market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The online pharmacy segment is expected to grow at the fastest CAGR due to the increasing adoption of online platforms and their integration with telemedicine services[1][4].
Price Projections and Affordability
The prices of loratadine vary based on the dosage form and quantity:
- Oral Tablets: A supply of 10 loratadine 10 mg oral tablets can cost around $10, depending on the pharmacy. Prices decrease with larger quantities, such as $0.29 per unit for a supply of 50 tablets[2].
- Oral Syrup: The cost for loratadine oral syrup can range from $12.45 for 118 milliliters to $15.50 for 240 milliliters[2].
- Chewable and Disintegrating Tablets: Prices for these forms range from $26.84 for 30 chewable tablets to $11.16 for 10 disintegrating tablets[2].
Regional Market Analysis
North America
North America dominates the loratadine market due to the high prevalence of seasonal and perennial allergies and the strong presence of manufacturers. The U.S. loratadine market was valued at USD 43.9 million in 2023 and is expected to grow at a CAGR of 2.6% over the forecast period[1][4][5].
Asia Pacific
The Asia Pacific region is predicted to witness the fastest CAGR over the forecast period. Factors such as increasing awareness of allergic ailments, a rising geriatric population prone to allergic conditions, and the prevalence of lifestyle diseases are driving market growth in this region[1][5].
Key Players and Market Concentration
The loratadine market is characterized by the presence of several key players, including Bayer AG, Pfizer Inc., Cadila Pharmaceuticals, Sun Pharmaceutical Industries Ltd., and Viatris Inc. The market concentration is low, indicating a competitive landscape[5].
Future Outlook
The loratadine market is expected to continue its steady growth driven by the increasing prevalence of allergic conditions and the convenience offered by various dosage forms. The integration of online pharmacy platforms with telemedicine is also expected to provide significant growth opportunities.
"The global prevalence of allergic rhinitis was estimated to be between 10% and 30% worldwide in 2021," according to the American Academy College of Allergy, Asthma & Immunology[1].
Key Takeaways
- The global loratadine market is valued at approximately USD 153.4 million in 2023 and is expected to grow at a CAGR of 2.9% from 2024 to 2030.
- North America dominates the market, while the Asia Pacific region is expected to witness the fastest growth.
- The market is driven by the increasing prevalence of allergic conditions, changing lifestyles, and favorable regulatory landscapes.
- The online pharmacy segment is expected to grow rapidly due to its convenience and integration with telemedicine.
- Prices for loratadine vary based on dosage form and quantity, with discounts available for larger supplies.
FAQs
What is the current global market size of loratadine?
The global loratadine market was valued at approximately USD 153.4 million in 2023[1].
Which region is expected to grow the fastest in the loratadine market?
The Asia Pacific region is predicted to witness the fastest CAGR over the forecast period[1][5].
What are the main drivers of the loratadine market growth?
The main drivers include the increasing prevalence of allergic conditions, changing lifestyles, and the favorable regulatory landscape[1][3][4].
Which segment dominates the loratadine market based on dosage form?
The tablets segment dominated the market in 2023, accounting for USD 63.5 million[4].
How has the COVID-19 pandemic impacted the loratadine market?
The COVID-19 pandemic has heightened awareness regarding respiratory health and led to increased demand for antihistamines like loratadine. It has also prompted studies on the potential of loratadine in managing COVID-19 symptoms[1][5].
What is the expected CAGR of the loratadine market from 2024 to 2030?
The loratadine market is expected to grow at a CAGR of 2.9% from 2024 to 2030[1].
Sources
- Grand View Research: Loratadine Market Size, Share, Growth, Trends Report, 2030
- Drugs.com: Loratadine Prices, Coupons, Copay Cards & Patient Assistance
- TechSci Research: Loratadine Market By Size, Share and Forecast 2029F
- GMI Insights: Loratadine Market Size, Share & Growth Report, 2024 – 2032
- Mordor Intelligence: Loratadine Market - Size, Analysis, Industry Share & Growth
More… ↓
